| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | cAMP-dependent protein kinase activity | 1.56e-06 | 7 | 72 | 3 | GO:0004691 | |
| GeneOntologyMolecularFunction | cyclic nucleotide-dependent protein kinase activity | 3.72e-06 | 9 | 72 | 3 | GO:0004690 | |
| GeneOntologyMolecularFunction | AMP-activated protein kinase activity | 5.30e-06 | 10 | 72 | 3 | GO:0004679 | |
| GeneOntologyMolecularFunction | phosphatidylinositol 3-kinase regulator activity | 3.53e-05 | 18 | 72 | 3 | GO:0035014 | |
| GeneOntologyMolecularFunction | telomerase RNA binding | 9.77e-05 | 25 | 72 | 3 | GO:0070034 | |
| GeneOntologyMolecularFunction | promoter-specific chromatin binding | 2.30e-04 | 83 | 72 | 4 | GO:1990841 | |
| GeneOntologyMolecularFunction | gamma-tubulin binding | 3.46e-04 | 38 | 72 | 3 | GO:0043015 | |
| GeneOntologyMolecularFunction | phosphatidylinositol 3-kinase inhibitor activity | 3.54e-04 | 8 | 72 | 2 | GO:0141039 | |
| GeneOntologyMolecularFunction | phosphatidylinositol-3,4,5-trisphosphate binding | 7.35e-04 | 49 | 72 | 3 | GO:0005547 | |
| GeneOntologyMolecularFunction | cytoskeletal motor activity | 8.75e-04 | 118 | 72 | 4 | GO:0003774 | |
| GeneOntologyMolecularFunction | ubiquitin protein ligase binding | 1.35e-03 | 337 | 72 | 6 | GO:0031625 | |
| GeneOntologyMolecularFunction | protein kinase activity | 1.40e-03 | 600 | 72 | 8 | GO:0004672 | |
| GeneOntologyMolecularFunction | actin binding | 1.68e-03 | 479 | 72 | 7 | GO:0003779 | |
| GeneOntologyMolecularFunction | sulfuric ester hydrolase activity | 1.68e-03 | 17 | 72 | 2 | GO:0008484 | |
| GeneOntologyMolecularFunction | cytoskeletal protein binding | WASH6P WASH3P MYO9A MYO9B STXBP5L INPPL1 STAU2 NDN SORBS1 KIF17 HNRNPU | 1.84e-03 | 1099 | 72 | 11 | GO:0008092 |
| GeneOntologyMolecularFunction | ubiquitin-like protein ligase binding | 1.84e-03 | 358 | 72 | 6 | GO:0044389 | |
| GeneOntologyMolecularFunction | protein serine kinase activity | 1.97e-03 | 363 | 72 | 6 | GO:0106310 | |
| GeneOntologyMolecularFunction | protein kinase A regulatory subunit binding | 3.65e-03 | 25 | 72 | 2 | GO:0034237 | |
| GeneOntologyMolecularFunction | phosphotransferase activity, alcohol group as acceptor | 3.93e-03 | 709 | 72 | 8 | GO:0016773 | |
| GeneOntologyBiologicalProcess | proteoglycan catabolic process | 6.60e-06 | 11 | 72 | 3 | GO:0030167 | |
| GeneOntologyBiologicalProcess | high-density lipoprotein particle assembly | 1.14e-05 | 13 | 72 | 3 | GO:0034380 | |
| GeneOntologyBiologicalProcess | regulation of plasma lipoprotein particle levels | 3.02e-05 | 103 | 72 | 5 | GO:0097006 | |
| GeneOntologyBiologicalProcess | dendritic transport | 3.80e-05 | 19 | 72 | 3 | GO:0098935 | |
| GeneOntologyBiologicalProcess | negative regulation of meiotic cell cycle | 7.83e-05 | 24 | 72 | 3 | GO:0051447 | |
| GeneOntologyBiologicalProcess | renal water homeostasis | 1.00e-04 | 26 | 72 | 3 | GO:0003091 | |
| GeneOntologyBiologicalProcess | negative regulation of catabolic process | 1.03e-04 | 418 | 72 | 8 | GO:0009895 | |
| GeneOntologyBiologicalProcess | plasma lipoprotein particle assembly | 1.40e-04 | 29 | 72 | 3 | GO:0034377 | |
| GeneOntologyBiologicalProcess | dendritic transport of ribonucleoprotein complex | 1.79e-04 | 6 | 72 | 2 | GO:0098961 | |
| GeneOntologyBiologicalProcess | dendritic transport of messenger ribonucleoprotein complex | 1.79e-04 | 6 | 72 | 2 | GO:0098963 | |
| GeneOntologyBiologicalProcess | positive regulation of cholesterol import | 1.79e-04 | 6 | 72 | 2 | GO:1904109 | |
| GeneOntologyBiologicalProcess | protein-lipid complex assembly | 2.06e-04 | 33 | 72 | 3 | GO:0065005 | |
| GeneOntologyBiologicalProcess | negative regulation of mRNA catabolic process | 2.44e-04 | 87 | 72 | 4 | GO:1902373 | |
| GeneOntologyBiologicalProcess | multicellular organismal-level water homeostasis | 2.46e-04 | 35 | 72 | 3 | GO:0050891 | |
| GeneOntologyBiologicalProcess | germ cell development | 2.71e-04 | 482 | 72 | 8 | GO:0007281 | |
| GeneOntologyBiologicalProcess | glycoprotein catabolic process | 3.95e-04 | 41 | 72 | 3 | GO:0006516 | |
| GeneOntologyBiologicalProcess | regulation of cholesterol import | 4.26e-04 | 9 | 72 | 2 | GO:0060620 | |
| GeneOntologyBiologicalProcess | heparan sulfate proteoglycan catabolic process | 4.26e-04 | 9 | 72 | 2 | GO:0030200 | |
| GeneOntologyBiologicalProcess | negative regulation of RNA catabolic process | 4.32e-04 | 101 | 72 | 4 | GO:1902369 | |
| GeneOntologyBiologicalProcess | cellular process involved in reproduction in multicellular organism | 4.91e-04 | 527 | 72 | 8 | GO:0022412 | |
| GeneOntologyBiologicalProcess | polar body extrusion after meiotic divisions | 5.31e-04 | 10 | 72 | 2 | GO:0040038 | |
| GeneOntologyCellularComponent | cAMP-dependent protein kinase complex | 4.82e-06 | 10 | 73 | 3 | GO:0005952 | |
| GeneOntologyCellularComponent | telomerase holoenzyme complex | 8.89e-05 | 25 | 73 | 3 | GO:0005697 | |
| GeneOntologyCellularComponent | serine/threonine protein kinase complex | 2.23e-04 | 157 | 73 | 5 | GO:1902554 | |
| GeneOntologyCellularComponent | protein kinase complex | 3.22e-04 | 170 | 73 | 5 | GO:1902911 | |
| GeneOntologyCellularComponent | dendrite cytoplasm | 3.41e-04 | 39 | 73 | 3 | GO:0032839 | |
| GeneOntologyCellularComponent | filopodium | 9.08e-04 | 123 | 73 | 4 | GO:0030175 | |
| GeneOntologyCellularComponent | ciliary base | 9.92e-04 | 56 | 73 | 3 | GO:0097546 | |
| GeneOntologyCellularComponent | transferase complex, transferring phosphorus-containing groups | 1.12e-03 | 335 | 73 | 6 | GO:0061695 | |
| GeneOntologyCellularComponent | WASH complex | 1.23e-03 | 15 | 73 | 2 | GO:0071203 | |
| GeneOntologyCellularComponent | BLOC-1 complex | 1.77e-03 | 18 | 73 | 2 | GO:0031083 | |
| Domain | Ubiquitin-rel_dom | 5.54e-04 | 184 | 68 | 5 | IPR029071 | |
| Domain | Kinase-like_dom | 7.65e-04 | 542 | 68 | 8 | IPR011009 | |
| Domain | AGC-kinase_C | 1.11e-03 | 56 | 68 | 3 | IPR000961 | |
| Domain | AGC_KINASE_CTER | 1.11e-03 | 56 | 68 | 3 | PS51285 | |
| Domain | S_TK_X | 1.11e-03 | 56 | 68 | 3 | SM00133 | |
| Domain | PROTEIN_KINASE_ATP | 1.38e-03 | 459 | 68 | 7 | PS00107 | |
| Domain | Sulfatase_CS | 1.52e-03 | 16 | 68 | 2 | IPR024607 | |
| Domain | SULFATASE_1 | 1.71e-03 | 17 | 68 | 2 | PS00523 | |
| Domain | SULFATASE_2 | 1.71e-03 | 17 | 68 | 2 | PS00149 | |
| Domain | Sulfatase | 1.92e-03 | 18 | 68 | 2 | PF00884 | |
| Domain | Sulfatase_N | 1.92e-03 | 18 | 68 | 2 | IPR000917 | |
| Domain | Prot_kinase_dom | 1.97e-03 | 489 | 68 | 7 | IPR000719 | |
| Domain | PROTEIN_KINASE_DOM | 2.07e-03 | 493 | 68 | 7 | PS50011 | |
| Domain | Protein_kinase_ATP_BS | 2.55e-03 | 379 | 68 | 6 | IPR017441 | |
| Domain | CRAL_TRIO | 2.62e-03 | 21 | 68 | 2 | PF00650 | |
| Domain | - | 3.15e-03 | 23 | 68 | 2 | 3.40.525.10 | |
| Domain | SEC14 | 3.71e-03 | 25 | 68 | 2 | SM00516 | |
| Domain | PHD | 4.19e-03 | 89 | 68 | 3 | SM00249 | |
| Domain | CRAL_TRIO | 4.32e-03 | 27 | 68 | 2 | PS50191 | |
| Domain | Znf_PHD | 4.46e-03 | 91 | 68 | 3 | IPR001965 | |
| Domain | CRAL-TRIO_dom | 4.64e-03 | 28 | 68 | 2 | IPR001251 | |
| Domain | ZF_PHD_2 | 5.03e-03 | 95 | 68 | 3 | PS50016 | |
| Domain | ZF_PHD_1 | 5.18e-03 | 96 | 68 | 3 | PS01359 | |
| Domain | ZINC_PROTEASE | 5.49e-03 | 98 | 68 | 3 | PS00142 | |
| Domain | RA | 5.67e-03 | 31 | 68 | 2 | SM00314 | |
| Domain | Alkaline_phosphatase_core | 5.67e-03 | 31 | 68 | 2 | IPR017850 | |
| Domain | Alkaline_Pase-like_a/b/a | 5.67e-03 | 31 | 68 | 2 | IPR017849 | |
| Domain | - | 5.67e-03 | 31 | 68 | 2 | 3.40.720.10 | |
| Domain | SH2 | 5.96e-03 | 101 | 68 | 3 | PF00017 | |
| Domain | MAGE | 6.80e-03 | 34 | 68 | 2 | SM01373 | |
| Domain | SH2 | 7.55e-03 | 110 | 68 | 3 | SM00252 | |
| Domain | MAGE | 7.60e-03 | 36 | 68 | 2 | PS50838 | |
| Domain | MAGE | 7.60e-03 | 36 | 68 | 2 | PF01454 | |
| Domain | RA | 7.60e-03 | 36 | 68 | 2 | PF00788 | |
| Domain | MHD_dom | 7.60e-03 | 36 | 68 | 2 | IPR002190 | |
| Domain | SH2 | 7.74e-03 | 111 | 68 | 3 | PS50001 | |
| Domain | SH2 | 7.93e-03 | 112 | 68 | 3 | IPR000980 | |
| Domain | - | 7.93e-03 | 112 | 68 | 3 | 3.30.505.10 | |
| Domain | SH3 | 7.96e-03 | 216 | 68 | 4 | SM00326 | |
| Domain | SH3 | 7.96e-03 | 216 | 68 | 4 | PS50002 | |
| Domain | RA | 8.01e-03 | 37 | 68 | 2 | PS50200 | |
| Domain | Myosin_head_motor_dom | 8.44e-03 | 38 | 68 | 2 | IPR001609 | |
| Pathway | REACTOME_PKA_MEDIATED_PHOSPHORYLATION_OF_KEY_METABOLIC_FACTORS | 4.71e-07 | 5 | 52 | 3 | M26988 | |
| Pathway | KEGG_MEDICUS_REFERENCE_PKA_HOLOENZYME | 1.64e-06 | 7 | 52 | 3 | M47896 | |
| Pathway | REACTOME_HDL_ASSEMBLY | 2.62e-06 | 8 | 52 | 3 | M27840 | |
| Pathway | REACTOME_ROBO_RECEPTORS_BIND_AKAP5 | 3.92e-06 | 9 | 52 | 3 | M27877 | |
| Pathway | KEGG_MEDICUS_REFERENCE_AVP_V2R_PKA_SIGNALING_PATHWAY | 5.58e-06 | 10 | 52 | 3 | M47648 | |
| Pathway | REACTOME_REGULATION_OF_GLYCOLYSIS_BY_FRUCTOSE_2_6_BISPHOSPHATE_METABOLISM | 1.02e-05 | 12 | 52 | 3 | M27950 | |
| Pathway | REACTOME_CREB1_PHOSPHORYLATION_THROUGH_THE_ACTIVATION_OF_ADENYLATE_CYCLASE | 1.02e-05 | 12 | 52 | 3 | M27363 | |
| Pathway | WP_DOPAMINE_METABOLISM | 1.32e-05 | 13 | 52 | 3 | M39622 | |
| Pathway | REACTOME_RET_SIGNALING | 1.36e-05 | 40 | 52 | 4 | M27746 | |
| Pathway | KEGG_MEDICUS_REFERENCE_EP_NE_ADRB_CAMP_SIGNALING_PATHWAY | 2.09e-05 | 15 | 52 | 3 | M47794 | |
| Pathway | KEGG_MEDICUS_REFERENCE_PTH_PTH1R_PKA_SIGNALING_PATHWAY | 2.09e-05 | 15 | 52 | 3 | M47504 | |
| Pathway | KEGG_MEDICUS_REFERENCE_DRD1_GNAS_AC_PKA_SIGNALING_PATHWAY | 2.56e-05 | 16 | 52 | 3 | M47551 | |
| Pathway | KEGG_MEDICUS_REFERENCE_LHCGR_GNAS_PKA_SIGNALING_PATHWAY | 2.56e-05 | 16 | 52 | 3 | M47645 | |
| Pathway | KEGG_MEDICUS_REFERENCE_FSHR_GNAS_PKA_SIGNALING_PATHWAY | 2.56e-05 | 16 | 52 | 3 | M47650 | |
| Pathway | REACTOME_RAP1_SIGNALLING | 2.56e-05 | 16 | 52 | 3 | M923 | |
| Pathway | REACTOME_PKA_ACTIVATION_IN_GLUCAGON_SIGNALLING | 3.10e-05 | 17 | 52 | 3 | M26995 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CX3CR1_GNAI_AC_PKA_SIGNALING_PATHWAY | 3.10e-05 | 17 | 52 | 3 | M47544 | |
| Pathway | REACTOME_SIGNALING_BY_VEGF | 4.29e-05 | 106 | 52 | 5 | M27077 | |
| Pathway | REACTOME_PLASMA_LIPOPROTEIN_ASSEMBLY | 4.40e-05 | 19 | 52 | 3 | M27841 | |
| Pathway | REACTOME_PKA_MEDIATED_PHOSPHORYLATION_OF_CREB | 5.16e-05 | 20 | 52 | 3 | M759 | |
| Pathway | WP_RAS_SIGNALING | 5.64e-05 | 184 | 52 | 6 | M39764 | |
| Pathway | REACTOME_CD209_DC_SIGN_SIGNALING | 6.01e-05 | 21 | 52 | 3 | M27485 | |
| Pathway | REACTOME_TRIGLYCERIDE_CATABOLISM | 9.07e-05 | 24 | 52 | 3 | M10064 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_GNAS_TO_CRHR_PKA_ACTH_SIGNALING_PATHWAY | 9.07e-05 | 24 | 52 | 3 | M47520 | |
| Pathway | REACTOME_DARPP_32_EVENTS | 9.07e-05 | 24 | 52 | 3 | M751 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HCMV_UL33_TO_GNAI_AC_PKA_SIGNALING_PATHWAY | 1.16e-04 | 26 | 52 | 3 | M47553 | |
| Pathway | PID_IL3_PATHWAY | 1.16e-04 | 26 | 52 | 3 | M182 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CRHR_PKA_ACTH_SIGNALING_PATHWAY | 1.30e-04 | 27 | 52 | 3 | M47518 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_RASD1_TO_CRHR_PKA_ACTH_SIGNALING_PATHWAY | 1.30e-04 | 27 | 52 | 3 | M47519 | |
| Pathway | REACTOME_INTRACELLULAR_SIGNALING_BY_SECOND_MESSENGERS | 1.41e-04 | 313 | 52 | 7 | M27867 | |
| Pathway | KEGG_INSULIN_SIGNALING_PATHWAY | 1.45e-04 | 137 | 52 | 5 | M18155 | |
| Pathway | KEGG_MEDICUS_REFERENCE_GHRHR_PKA_GH_SIGNALING_PATHWAY | 1.45e-04 | 28 | 52 | 3 | M47647 | |
| Pathway | WP_LIPID_METABOLISM_PATHWAY | 1.62e-04 | 29 | 52 | 3 | M39762 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TSH_TG_SIGNALING_PATHWAY | 1.62e-04 | 29 | 52 | 3 | M47627 | |
| Pathway | WP_CANNABINOID_RECEPTOR_SIGNALING | 1.62e-04 | 29 | 52 | 3 | M39676 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_GNAS_TO_ACTH_CORTISOL_SIGNALING_PATHWAY | 1.62e-04 | 29 | 52 | 3 | M47515 | |
| Pathway | WP_GPR143_IN_MELANOCYTES_AND_RETINAL_PIGMENT_EPITHELIUM_CELLS | 1.79e-04 | 30 | 52 | 3 | M42578 | |
| Pathway | KEGG_MEDICUS_VARIANT_CYP11B1_CYP11B2_FUSION_TO_ACTH_CORTISOL_SIGNALING_PATHWAY | 1.98e-04 | 31 | 52 | 3 | M47507 | |
| Pathway | REACTOME_GLUCAGON_SIGNALING_IN_METABOLIC_REGULATION | 1.98e-04 | 6 | 52 | 2 | MM14628 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ACTH_CORTISOL_SIGNALING_PATHWAY | 2.18e-04 | 32 | 52 | 3 | M47506 | |
| Pathway | REACTOME_NERVOUS_SYSTEM_DEVELOPMENT | 2.25e-04 | 575 | 52 | 9 | M29853 | |
| Pathway | WP_CARDIOMYOCYTE_SIGNALING_CONVERGING_ON_TITIN | 2.39e-04 | 33 | 52 | 3 | M48071 | |
| Pathway | REACTOME_GLUCAGON_SIGNALING_IN_METABOLIC_REGULATION | 2.39e-04 | 33 | 52 | 3 | M11575 | |
| Pathway | KEGG_PROGESTERONE_MEDIATED_OOCYTE_MATURATION | 2.67e-04 | 85 | 52 | 4 | M3578 | |
| Pathway | REACTOME_HDL_ASSEMBLY | 2.77e-04 | 7 | 52 | 2 | MM15560 | |
| Pathway | KEGG_MEDICUS_REFERENCE_HEPARAN_SULFATE_DEGRADATION | 2.77e-04 | 7 | 52 | 2 | M47608 | |
| Pathway | KEGG_PRION_DISEASES | 2.85e-04 | 35 | 52 | 3 | M13036 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ADRB3_UCP1_SIGNALING_PATHWAY | 2.85e-04 | 35 | 52 | 3 | M47969 | |
| Pathway | KEGG_APOPTOSIS | 2.92e-04 | 87 | 52 | 4 | M8492 | |
| Pathway | PID_GMCSF_PATHWAY | 3.10e-04 | 36 | 52 | 3 | M22 | |
| Pathway | REACTOME_CA_DEPENDENT_EVENTS | 3.37e-04 | 37 | 52 | 3 | M749 | |
| Pathway | REACTOME_RET_SIGNALING | 3.65e-04 | 38 | 52 | 3 | MM15493 | |
| Pathway | REACTOME_TRIGLYCERIDE_METABOLISM | 3.65e-04 | 38 | 52 | 3 | M27856 | |
| Pathway | REACTOME_NERVOUS_SYSTEM_DEVELOPMENT | 3.79e-04 | 261 | 52 | 6 | MM15676 | |
| Pathway | REACTOME_ACTIVATION_OF_NMDA_RECEPTORS_AND_POSTSYNAPTIC_EVENTS | 3.93e-04 | 94 | 52 | 4 | M2843 | |
| Pathway | WP_COMMON_PATHWAYS_UNDERLYING_DRUG_ADDICTION | 4.57e-04 | 41 | 52 | 3 | M39655 | |
| Pathway | REACTOME_INTERLEUKIN_3_INTERLEUKIN_5_AND_GM_CSF_SIGNALING | 4.57e-04 | 41 | 52 | 3 | MM15162 | |
| Pathway | REACTOME_DAG_AND_IP3_SIGNALING | 4.57e-04 | 41 | 52 | 3 | M512 | |
| Pathway | WP_HIPPO_SIGNALING_REGULATION | 4.60e-04 | 98 | 52 | 4 | M39830 | |
| Pathway | REACTOME_GLUCAGON_LIKE_PEPTIDE_1_GLP1_REGULATES_INSULIN_SECRETION | 4.91e-04 | 42 | 52 | 3 | M791 | |
| Pathway | REACTOME_DEVELOPMENTAL_BIOLOGY | EOMES HOXA4 MAG TRIM33 TRIO MYO9B PIK3CB UNC5B CSNK2A2 PRKACA PRKACB PRKACG MED13 HNRNPU | 5.06e-04 | 1432 | 52 | 14 | M509 |
| Pathway | WP_HEDGEHOG_SIGNALING_WP4249 | 5.26e-04 | 43 | 52 | 3 | M39706 | |
| Pathway | REACTOME_ADORA2B_MEDIATED_ANTI_INFLAMMATORY_CYTOKINES_PRODUCTION | 5.26e-04 | 43 | 52 | 3 | M29837 | |
| Pathway | REACTOME_VASOPRESSIN_REGULATES_RENAL_WATER_HOMEOSTASIS_VIA_AQUAPORINS | 5.26e-04 | 43 | 52 | 3 | M933 | |
| Pathway | REACTOME_SIGNALING_BY_VEGF | 5.56e-04 | 103 | 52 | 4 | MM14752 | |
| Pathway | WP_VASOPRESSINREGULATED_WATER_REABSORPTION | 5.64e-04 | 44 | 52 | 3 | M42554 | |
| Pathway | KEGG_VASOPRESSIN_REGULATED_WATER_REABSORPTION | 5.64e-04 | 44 | 52 | 3 | M9011 | |
| Pathway | REACTOME_GPER1_SIGNALING | 6.02e-04 | 45 | 52 | 3 | M45008 | |
| Pathway | REACTOME_METABOLISM_OF_CARBOHYDRATES | 6.38e-04 | 288 | 52 | 6 | M16864 | |
| Pathway | BIOCARTA_AKAP95_PATHWAY | 7.19e-04 | 11 | 52 | 2 | M5731 | |
| Pathway | BIOCARTA_PLCE_PATHWAY | 7.19e-04 | 11 | 52 | 2 | M5576 | |
| Pathway | REACTOME_MUCOPOLYSACCHARIDOSES | 7.19e-04 | 11 | 52 | 2 | M27160 | |
| Pathway | BIOCARTA_CFTR_PATHWAY | 7.19e-04 | 11 | 52 | 2 | M12399 | |
| Pathway | BIOCARTA_AGPCR_PATHWAY | 7.19e-04 | 11 | 52 | 2 | M19829 | |
| Pathway | BIOCARTA_AKAP13_PATHWAY | 7.19e-04 | 11 | 52 | 2 | M17668 | |
| Pathway | PID_PI3KCI_PATHWAY | 7.28e-04 | 48 | 52 | 3 | M141 | |
| Pathway | REACTOME_INTERLEUKIN_3_INTERLEUKIN_5_AND_GM_CSF_SIGNALING | 7.28e-04 | 48 | 52 | 3 | M914 | |
| Pathway | BIOCARTA_CARM1_PATHWAY | 8.60e-04 | 12 | 52 | 2 | M7968 | |
| Pathway | KEGG_TASTE_TRANSDUCTION | 9.21e-04 | 52 | 52 | 3 | M5785 | |
| Pathway | REACTOME_AQUAPORIN_MEDIATED_TRANSPORT | 9.21e-04 | 52 | 52 | 3 | M920 | |
| Pathway | BIOCARTA_DREAM_PATHWAY | 1.01e-03 | 13 | 52 | 2 | M18899 | |
| Pathway | WP_HIPPOMERLIN_SIGNALING_DYSREGULATION | 1.02e-03 | 121 | 52 | 4 | M39823 | |
| Pathway | REACTOME_G_PROTEIN_MEDIATED_EVENTS | 1.03e-03 | 54 | 52 | 3 | M26911 | |
| Pathway | KEGG_VIBRIO_CHOLERAE_INFECTION | 1.03e-03 | 54 | 52 | 3 | M17906 | |
| Pathway | KEGG_HEDGEHOG_SIGNALING_PATHWAY | 1.14e-03 | 56 | 52 | 3 | M1053 | |
| Pathway | BIOCARTA_GATA3_PATHWAY | 1.18e-03 | 14 | 52 | 2 | M1394 | |
| Pathway | BIOCARTA_AKAPCENTROSOME_PATHWAY | 1.18e-03 | 14 | 52 | 2 | M15347 | |
| Pathway | KEGG_MEDICUS_VARIANT_DUPLICATION_OR_MUTATION_ACTIVATED_FLT3_TO_RAS_PI3K_SIGNALING_PATHWAY | 1.18e-03 | 14 | 52 | 2 | M47390 | |
| Pathway | REACTOME_LEISHMANIA_INFECTION | 1.24e-03 | 219 | 52 | 5 | M29836 | |
| Pathway | REACTOME_RAP1_SIGNALLING | 1.36e-03 | 15 | 52 | 2 | MM15019 | |
| Pathway | REACTOME_POST_NMDA_RECEPTOR_ACTIVATION_EVENTS | 1.36e-03 | 15 | 52 | 2 | MM15103 | |
| Pathway | KEGG_MEDICUS_REFERENCE_FLT3LG_FLT3_RAS_PI3K_SIGNALING_PATHWAY | 1.36e-03 | 15 | 52 | 2 | M47475 | |
| Pathway | REACTOME_DEGRADATION_OF_GLI1_BY_THE_PROTEASOME | 1.40e-03 | 60 | 52 | 3 | M27470 | |
| Pathway | BIOCARTA_CK1_PATHWAY | 1.55e-03 | 16 | 52 | 2 | M16626 | |
| Pathway | REACTOME_DARPP_32_EVENTS | 1.55e-03 | 16 | 52 | 2 | MM14699 | |
| Pathway | REACTOME_PKA_MEDIATED_PHOSPHORYLATION_OF_CREB | 1.55e-03 | 16 | 52 | 2 | MM14492 | |
| Pathway | BIOCARTA_SHH_PATHWAY | 1.55e-03 | 16 | 52 | 2 | M11792 | |
| Pathway | REACTOME_METABOLISM_OF_LIPIDS | EPHX2 PIK3CB CSNK2A2 INPPL1 PRKACA PRKACB PRKACG ETNPPL MED13 | 1.63e-03 | 757 | 52 | 9 | M27451 |
| Pathway | REACTOME_PLASMA_LIPOPROTEIN_ASSEMBLY | 1.75e-03 | 17 | 52 | 2 | MM15561 | |
| Pathway | REACTOME_GERM_LAYER_FORMATION_AT_GASTRULATION | 1.75e-03 | 17 | 52 | 2 | M45017 | |
| Pubmed | 9.25e-09 | 3 | 74 | 3 | 2342480 | ||
| Pubmed | 9.25e-09 | 3 | 74 | 3 | 12842892 | ||
| Pubmed | 9.25e-09 | 3 | 74 | 3 | 19383776 | ||
| Pubmed | 3.69e-08 | 4 | 74 | 3 | 18385332 | ||
| Pubmed | 9.22e-08 | 5 | 74 | 3 | 12972513 | ||
| Pubmed | Characterization of the murine orthologue of a novel human subtelomeric multigene family. | 9.22e-08 | 5 | 74 | 3 | 11701968 | |
| Pubmed | 9.22e-08 | 5 | 74 | 3 | 19483721 | ||
| Pubmed | HIV-1 Tat binds to SH3 domains: cellular and viral outcome of Tat/Grb2 interaction. | 9.22e-08 | 5 | 74 | 3 | 21745501 | |
| Pubmed | 9.22e-08 | 5 | 74 | 3 | 9540970 | ||
| Pubmed | PKA-mediated stabilization of FoxH1 negatively regulates ERalpha activity. | 9.22e-08 | 5 | 74 | 3 | 19711044 | |
| Pubmed | 1.34e-07 | 22 | 74 | 4 | 9151826 | ||
| Pubmed | Human subtelomeric WASH genes encode a new subclass of the WASP family. | 1.84e-07 | 6 | 74 | 3 | 18159949 | |
| Pubmed | Architectural DNA-binding properties of the spermatidal transition proteins 1 and 2. | 1.84e-07 | 6 | 74 | 3 | 9837753 | |
| Pubmed | Ser276 phosphorylation of NF-kB p65 by MSK1 controls SCF expression in inflammation. | 1.84e-07 | 6 | 74 | 3 | 19197368 | |
| Pubmed | 3.22e-07 | 7 | 74 | 3 | 16407073 | ||
| Pubmed | Phosphorylation of HIV Nef by cAMP-dependent protein kinase. | 3.22e-07 | 7 | 74 | 3 | 15629779 | |
| Pubmed | CCL3L1 prevents gp120-induced neuron death via the CREB cell signaling pathway. | 5.14e-07 | 8 | 74 | 3 | 19100722 | |
| Pubmed | 5.14e-07 | 8 | 74 | 3 | 12628924 | ||
| Pubmed | 7.70e-07 | 9 | 74 | 3 | 7688126 | ||
| Pubmed | HIV-1 Tat-peptide inhibits protein kinase C and protein kinase A through substrate competition. | 1.10e-06 | 10 | 74 | 3 | 20433920 | |
| Pubmed | 2.01e-06 | 12 | 74 | 3 | 10830164 | ||
| Pubmed | Phosphorylation of APOBEC3G by protein kinase A regulates its interaction with HIV-1 Vif. | 2.60e-06 | 13 | 74 | 3 | 18836454 | |
| Pubmed | 2.60e-06 | 13 | 74 | 3 | 19895210 | ||
| Pubmed | The HIV-1 matrix protein p17 activates the transcription factors c-Myc and CREB in human B cells. | 2.60e-06 | 13 | 74 | 3 | 20402410 | |
| Pubmed | 2.60e-06 | 13 | 74 | 3 | 20392842 | ||
| Pubmed | cAMP-dependent protein kinase: framework for a diverse family of regulatory enzymes. | 4.13e-06 | 15 | 74 | 3 | 2165385 | |
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 23568409 | ||
| Pubmed | Endocytic depletion of L-MAG from CNS myelin in quaking mice. | 4.47e-06 | 2 | 74 | 2 | 8557747 | |
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 33046503 | ||
| Pubmed | Evidence for a second isoform of the catalytic subunit of cAMP-dependent protein kinase. | 4.47e-06 | 2 | 74 | 2 | 3023318 | |
| Pubmed | Global consequences of activation loop phosphorylation on protein kinase A. | 4.47e-06 | 2 | 74 | 2 | 19965870 | |
| Pubmed | Necdin interacts with the ribonucleoprotein hnRNP U in the nuclear matrix. | 4.47e-06 | 2 | 74 | 2 | 11813259 | |
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 32451867 | ||
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 15039079 | ||
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 7545761 | ||
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 12180908 | ||
| Pubmed | PKA mediates modality-specific modulation of the mechanically gated ion channel PIEZO2. | 4.47e-06 | 2 | 74 | 2 | 37146970 | |
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 31678302 | ||
| Pubmed | Mechanism of Bruton's tyrosine kinase-mediated recruitment and regulation of TFII-I. | 4.47e-06 | 2 | 74 | 2 | 14623887 | |
| Pubmed | Systems-level identification of PKA-dependent signaling in epithelial cells. | 4.47e-06 | 2 | 74 | 2 | 28973931 | |
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 36152045 | ||
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 38841868 | ||
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 10373551 | ||
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 37871652 | ||
| Pubmed | Molecular and behavioral effects of a null mutation in all PKA C beta isoforms. | 4.47e-06 | 2 | 74 | 2 | 12139926 | |
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 36226489 | ||
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 15199069 | ||
| Pubmed | Targeting BTK for the treatment of FLT3-ITD mutated acute myeloid leukemia. | 4.47e-06 | 2 | 74 | 2 | 26292723 | |
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 2833513 | ||
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 20956316 | ||
| Pubmed | Multiple APOBEC3 restriction factors for HIV-1 and one Vif to rule them all. | 6.15e-06 | 17 | 74 | 3 | 24189052 | |
| Pubmed | 1.20e-05 | 21 | 74 | 3 | 22114277 | ||
| Pubmed | 1.20e-05 | 21 | 74 | 3 | 9671211 | ||
| Pubmed | 1.34e-05 | 3 | 74 | 2 | 38086439 | ||
| Pubmed | 1.34e-05 | 3 | 74 | 2 | 2454205 | ||
| Pubmed | 1.34e-05 | 3 | 74 | 2 | 25605370 | ||
| Pubmed | Involvement of the catalytic subunit of protein kinase A and of HA95 in pre-mRNA splicing. | 1.34e-05 | 3 | 74 | 2 | 17594903 | |
| Pubmed | WASH Regulates Glucose Homeostasis by Facilitating Glut2 Receptor Recycling in Pancreatic β-Cells. | 1.34e-05 | 3 | 74 | 2 | 30425062 | |
| Pubmed | 1.34e-05 | 3 | 74 | 2 | 8548807 | ||
| Pubmed | 1.34e-05 | 3 | 74 | 2 | 18380891 | ||
| Pubmed | 1.34e-05 | 3 | 74 | 2 | 25225459 | ||
| Pubmed | 1.59e-05 | 23 | 74 | 3 | 9730685 | ||
| Pubmed | 1.59e-05 | 23 | 74 | 3 | 9278385 | ||
| Pubmed | RHOG TRIM33 GAR1 TRIO ADAMTS9 RBL2 TRPS1 SORBS1 IDS QKI MED13 ECE2 | 1.62e-05 | 1285 | 74 | 12 | 35914814 | |
| Pubmed | 2.61e-05 | 27 | 74 | 3 | 21651489 | ||
| Pubmed | 2.67e-05 | 4 | 74 | 2 | 23275443 | ||
| Pubmed | 2.67e-05 | 4 | 74 | 2 | 32492429 | ||
| Pubmed | 2.67e-05 | 4 | 74 | 2 | 15649893 | ||
| Pubmed | 2.67e-05 | 4 | 74 | 2 | 22096577 | ||
| Pubmed | 2.67e-05 | 4 | 74 | 2 | 9722526 | ||
| Pubmed | The hepatic WASH complex is required for efficient plasma LDL and HDL cholesterol clearance. | 2.67e-05 | 4 | 74 | 2 | 31167970 | |
| Pubmed | BAP-135, a target for Bruton's tyrosine kinase in response to B cell receptor engagement. | 2.67e-05 | 4 | 74 | 2 | 9012831 | |
| Pubmed | 2.67e-05 | 4 | 74 | 2 | 9837922 | ||
| Pubmed | 2.67e-05 | 4 | 74 | 2 | 9407077 | ||
| Pubmed | 2.67e-05 | 4 | 74 | 2 | 3418751 | ||
| Pubmed | 2.67e-05 | 4 | 74 | 2 | 7873880 | ||
| Pubmed | 2.67e-05 | 4 | 74 | 2 | 32879135 | ||
| Pubmed | 2.67e-05 | 4 | 74 | 2 | 11934902 | ||
| Pubmed | 2.67e-05 | 4 | 74 | 2 | 23116618 | ||
| Pubmed | 2.67e-05 | 4 | 74 | 2 | 22718907 | ||
| Pubmed | BIG1 is a binding partner of myosin IXb and regulates its Rho-GTPase activating protein activity. | 2.67e-05 | 4 | 74 | 2 | 15644318 | |
| Pubmed | Role of caveolin-1 in the modulation of lipolysis and lipid droplet formation. | 2.67e-05 | 4 | 74 | 2 | 15111495 | |
| Pubmed | 2.67e-05 | 4 | 74 | 2 | 28342926 | ||
| Pubmed | 2.67e-05 | 4 | 74 | 2 | 11373296 | ||
| Pubmed | Rap1GAP2 is a new GTPase-activating protein of Rap1 expressed in human platelets. | 2.67e-05 | 4 | 74 | 2 | 15632203 | |
| Pubmed | 2.67e-05 | 4 | 74 | 2 | 12721358 | ||
| Pubmed | GPCR signaling inhibits mTORC1 via PKA phosphorylation of Raptor. | 2.67e-05 | 4 | 74 | 2 | 31112131 | |
| Pubmed | 2.67e-05 | 4 | 74 | 2 | 12504111 | ||
| Pubmed | Discrete control of TRPV4 channel function in the distal nephron by protein kinases A and C. | 2.67e-05 | 4 | 74 | 2 | 23709216 | |
| Pubmed | 2.67e-05 | 4 | 74 | 2 | 24886983 | ||
| Pubmed | Germline and Mosaic Variants in PRKACA and PRKACB Cause a Multiple Congenital Malformation Syndrome. | 2.67e-05 | 4 | 74 | 2 | 33058759 | |
| Pubmed | 2.67e-05 | 4 | 74 | 2 | 21852354 | ||
| Pubmed | 3.05e-05 | 83 | 74 | 4 | 28794006 | ||
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | 3.60e-05 | 588 | 74 | 8 | 38580884 | |
| Pubmed | Genome-wide CRISPR screening reveals genetic modifiers of mutant EGFR dependence in human NSCLC. | 3.89e-05 | 293 | 74 | 6 | 31741433 | |
| Pubmed | Developmentally acquired PKA localisation in mouse oocytes and embryos. | 4.45e-05 | 5 | 74 | 2 | 18367160 | |
| Pubmed | 4.45e-05 | 5 | 74 | 2 | 15096481 | ||
| Pubmed | Endosomal WASH and exocyst complexes control exocytosis of MT1-MMP at invadopodia. | 4.45e-05 | 5 | 74 | 2 | 24344185 | |
| Pubmed | Signalling of the BCR is regulated by a lipid rafts-localised transcription factor, Bright. | 4.45e-05 | 5 | 74 | 2 | 19214191 | |
| Pubmed | Involvement of protein kinase A in patterning of the mouse somatosensory cortex. | 4.45e-05 | 5 | 74 | 2 | 16707791 | |
| Interaction | PKIG interactions | 9.01e-06 | 12 | 71 | 3 | int:PKIG | |
| Interaction | TNP1 interactions | 9.01e-06 | 12 | 71 | 3 | int:TNP1 | |
| GeneFamily | Myosins, class IX | 5.53e-06 | 2 | 43 | 2 | 1103 | |
| GeneFamily | Wiskott-Aldrich Syndrome protein family | 6.87e-06 | 16 | 43 | 3 | 14 | |
| GeneFamily | Sulfatases | 8.25e-04 | 18 | 43 | 2 | 410 | |
| GeneFamily | SH2 domain containing | 1.78e-03 | 101 | 43 | 3 | 741 | |
| GeneFamily | WD repeat domain containing | 3.41e-03 | 262 | 43 | 4 | 362 | |
| GeneFamily | MAGE family | 4.07e-03 | 40 | 43 | 2 | 1136 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 6.59e-03 | 161 | 43 | 3 | 593 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte-Z|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.26e-08 | 192 | 74 | 7 | 8dc3016601148243196e925641c9507e9d58c9e0 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte-E|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 8.64e-07 | 194 | 74 | 6 | cb0422e7607dbd77204428b7e2c70dfe14a6ca11 | |
| ToppCell | facs-Liver-Liver_non-hepato/SCs_st-18m-Lymphocytic-T_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.96e-06 | 164 | 74 | 5 | 1a9b444d2c6abcc83d4355ec5228b27541df2bd0 | |
| ToppCell | droplet-Marrow-BM-1m-Hematologic-hematopoietic_precursor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.25e-05 | 180 | 74 | 5 | ff34195bb7325e61fbf823c103c5e6115d8f1248 | |
| ToppCell | (3)_Mast_cells|World / Oesophagus cell shreds on cell class (v1) and cell subclass (v1) | 1.39e-05 | 184 | 74 | 5 | dbfad62b925d835632b39a88ab95bd9af9cb7bee | |
| ToppCell | (3)_Mast_cell|World / Oesophagus cell shreds on cell class (v1) and cell subclass (v1) | 1.39e-05 | 184 | 74 | 5 | 482907d3669597e25c8ff3e9a802a31415a0d654 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.50e-05 | 187 | 74 | 5 | 85f1678338a47d91e296f0620d4887f057eb7e70 | |
| ToppCell | facs-Pancreas-Endocrine-3m|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.66e-05 | 191 | 74 | 5 | b3de0393d6510543533cd851e47a0f95739a0e4e | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.70e-05 | 192 | 74 | 5 | dc40ef2341e5d6a6d479f140e023fe1bf687928d | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte-C|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.70e-05 | 192 | 74 | 5 | 3ce5dbde41aeb73d49f2c7991d34682f0827fa5a | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.75e-05 | 193 | 74 | 5 | 9f9eb241b0b82a6f12de6921c3acf6fed7cf65bb | |
| ToppCell | Neuronal-Inhibitory-iB-iB_3(PVALB-SST)|Neuronal / cells hierarchy compared to all cells using T-Statistic | 2.07e-05 | 200 | 74 | 5 | 107854f4855fc99c9f7e737eb246f0d868e6c5fd | |
| ToppCell | NS-control-d_0-4-Myeloid-Monocyte-derived_DC|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 5.98e-05 | 127 | 74 | 4 | 1f9039d2a9e418c41716c3608d4d03574b71904a | |
| ToppCell | control-Myeloid-Monocyte-derived_DC|control / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 6.16e-05 | 128 | 74 | 4 | 4a1f7b76b64df06531db79e427eda084374ce7b5 | |
| ToppCell | TCGA-Mesothelium-Primary_Tumor-Mesothelioma-Epitheliod-3|TCGA-Mesothelium / Sample_Type by Project: Shred V9 | 8.02e-05 | 137 | 74 | 4 | a1e34ebbeda3d5a4f14917282d44fcb4dcbf3133 | |
| ToppCell | Adult-Mesenchymal-vascular_smooth_muscle_cell-D122|Adult / Lineage, Cell type, age group and donor | 1.46e-04 | 160 | 74 | 4 | fd14dfeb7021a4b7299371854dc8fc1fd66c8dae | |
| ToppCell | facs-Lung-nan-3m-Lymphocytic-Natural_Killer|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.50e-04 | 161 | 74 | 4 | ae1cee34361dde9964581cca99a29578c3b3bd99 | |
| ToppCell | facs-Lung-nan-3m-Lymphocytic-NK_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.50e-04 | 161 | 74 | 4 | 33de3e8b3238fcfc66dfbf89a913a07d464d6c35 | |
| ToppCell | droplet-Marrow-BM-30m-Lymphocytic-NK_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.61e-04 | 164 | 74 | 4 | b77995958c938e10a526118f75d78cee72e0b207 | |
| ToppCell | facs-Liver-Liver_non-hepato/SCs-18m-Myeloid-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.61e-04 | 164 | 74 | 4 | 45a6d809d92fd4eee906da3c812282bacffc9f2f | |
| ToppCell | facs-Liver-Liver_non-hepato/SCs-18m-Myeloid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.61e-04 | 164 | 74 | 4 | aa4358311fc767c292897e3328309d1bcda392d4 | |
| ToppCell | facs-Marrow-T_cells-18m-Lymphocytic-Klrb1a/b/c(-)_NK_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.64e-04 | 165 | 74 | 4 | eeb58d4db64ad37dc6b441eab22b05c24862e1a9 | |
| ToppCell | droplet-Spleen-SPLEEN-1m-Lymphocytic-NK_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.64e-04 | 165 | 74 | 4 | 8741df8066a44c841752a99ad306d26ea68f5344 | |
| ToppCell | moderate-Myeloid-Mast_cell|Myeloid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.68e-04 | 166 | 74 | 4 | c3835b424c63bf11a4e2c47635dc3787fc4a637a | |
| ToppCell | 10x5'-bone_marrow-Hematopoietic_progenitors-Progenitor_Erythro-Mega|bone_marrow / Manually curated celltypes from each tissue | 1.68e-04 | 166 | 74 | 4 | a853005a5587d42daecdf2e23a93109919021a4f | |
| ToppCell | TCGA-Stomach-Primary_Tumor-Stomach_Adenocarcinoma-Stomach_Adenocarcinoma_-_Diffuse-3|TCGA-Stomach / Sample_Type by Project: Shred V9 | 1.72e-04 | 167 | 74 | 4 | d2230c894ccf9dbba9196e079ae81f384d43da63 | |
| ToppCell | ASK440-Epithelial-Transformed_epithelium|ASK440 / Donor, Lineage and Cell class of Lung cells from Dropseq | 1.93e-04 | 172 | 74 | 4 | df3800bcd9777d02900eba0cfc26ab73de8a1d95 | |
| ToppCell | 5'-Adult-LargeIntestine-Hematopoietic-Myeloid-cDC1|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.97e-04 | 173 | 74 | 4 | d13ae4046a25ee0fb492ddedf44583a879a432e9 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.06e-04 | 175 | 74 | 4 | 12f5fd83c7710fc0c77406f765d9cbd133433b8b | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_cortex-lymphatic_endothelial_cell_of_renal_cortex_prolif|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.10e-04 | 176 | 74 | 4 | 8eb91dcf55d4e3e28a72d447181bf6d2ad891fc6 | |
| ToppCell | facs-Liver-Liver_non-hepato/SCs-18m-Lymphocytic-CD8-positive,_alpha-beta_T_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.15e-04 | 177 | 74 | 4 | b8de0fc92691a6d6759c743195b11edd2d63f265 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Macroglial|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.29e-04 | 180 | 74 | 4 | 350ba05cec45a788ab33530cc1346daddb00f884 | |
| ToppCell | Thalamus-Macroglia|Thalamus / BrainAtlas - Mouse McCarroll V32 | 2.34e-04 | 181 | 74 | 4 | 4f62b63854a4e9fea6e839f0340e78392c66fb0e | |
| ToppCell | COVID-19-Endothelial_cells-Endothelial_cells_(other)|COVID-19 / group, cell type (main and fine annotations) | 2.34e-04 | 181 | 74 | 4 | 26eb4ee57a70dbf54e096b73129fda9dfda1f6ec | |
| ToppCell | critical-Myeloid-Mast_cell|Myeloid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 2.34e-04 | 181 | 74 | 4 | f0d81ae74d3f32979624a94b2ef93774831a7970 | |
| ToppCell | facs-Lung-Endomucin-24m-Endothelial-Capillary_Aerocyte_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.34e-04 | 181 | 74 | 4 | cd81bc307e2bc42c1e9b24d5645ab65fa18c6133 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Macroglial-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.39e-04 | 182 | 74 | 4 | 0beffe6b9b36cfd196ec98a18f6ded080c162f90 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Macroglial-oligodendrocyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.44e-04 | 183 | 74 | 4 | 038edbc879db7bca795fb2f08e47c42476946161 | |
| ToppCell | RA-13._Vascular_Smooth_Muscle|World / Chamber and Cluster_Paper | 2.44e-04 | 183 | 74 | 4 | cae2ee08f985a6f005b4b8e959e465350315156a | |
| ToppCell | Cerebellum-Macroglia|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 2.49e-04 | 184 | 74 | 4 | 91b047a01d2cad231308279ca37fa699630f7864 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L4-6_SST_MTHFD2P6|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.49e-04 | 184 | 74 | 4 | 23515c28e1f42aab29cef9e5b4a7f45bda7f5520 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum_-18m-Neuronal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.49e-04 | 184 | 74 | 4 | 7d9bcdaff8cbea4c50ab7db0f8e01f6bbd0ef593 | |
| ToppCell | droplet-Marrow-nan-21m-Hematologic-hematopoietic_precursor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.49e-04 | 184 | 74 | 4 | 7e129862f8d2353387999e633725325c4d8cb42e | |
| ToppCell | wk_20-22-Epithelial-PNS-intermediate_Schwann|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 2.49e-04 | 184 | 74 | 4 | 4e3ba64692868563a579902aa9c6f88cab5bce26 | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Epithelial-Epcam____podocyte|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.54e-04 | 185 | 74 | 4 | 872720275789d249c9859de825a923803d458875 | |
| ToppCell | facs-Lung-Endomucin-3m-Endothelial-Capillary_Aerocyte_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.60e-04 | 186 | 74 | 4 | 9d6cb36aa0aae69fe584dad31deafcfdcc9fd1db | |
| ToppCell | 356C-Endothelial_cells-Endothelial-C_(Capillary_Aerocyte_)-|356C / Donor, Lineage, Cell class and subclass (all cells) | 2.60e-04 | 186 | 74 | 4 | f0b78c7ee20279970ea8961bf59acb5262f2dce5 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L3-5_SST_MAFB|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.60e-04 | 186 | 74 | 4 | 96f6603cc75fa1ffc2a2fdb94ec0ec09498e540a | |
| ToppCell | 356C-Endothelial_cells-Endothelial-C_(Capillary_Aerocyte_)|356C / Donor, Lineage, Cell class and subclass (all cells) | 2.60e-04 | 186 | 74 | 4 | 2b3c814a7dee8286ea113c63dc3de5daf0257d37 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Endothelial-lymphatic_endothelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.65e-04 | 187 | 74 | 4 | 65d406122dffe18279f14a1ed35ba091730b97be | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_cortex-lymphatic_endothelial_cell_of_renal_cortex|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.65e-04 | 187 | 74 | 4 | 4c15c0ed41a55271fc793cb76fee97fa64190369 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_cortex|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.65e-04 | 187 | 74 | 4 | 5274f2b302bbf7fed30c480af4f35058d2cf61e0 | |
| ToppCell | Adult-Endothelial-endothelial_cell_of_lymph_vessel-D175|Adult / Lineage, Cell type, age group and donor | 2.65e-04 | 187 | 74 | 4 | 1e52d3d9d664c813d859b5b75e4c07b218818f95 | |
| ToppCell | 3'-Adult-LargeIntestine-Hematopoietic-Myeloid-Mast_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.70e-04 | 188 | 74 | 4 | 3fe9d698ff8f540edebf8609e7d42d3f81271edb | |
| ToppCell | NS-critical-d_0-4-Lymphoid-CTL|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.76e-04 | 189 | 74 | 4 | fb7572fb4c7c43886d57a025decad076f32a14c4 | |
| ToppCell | 3'-Distal_airway-Immune_Myeloid_mast-Myeloid_Mast/Baso-mast_cell-Mast_cells-Mast_cells_L.1.4.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.76e-04 | 189 | 74 | 4 | f3cb1a8ddf7a4a95fb1b6e8fe5aa63ef037ca7a6 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_3|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.81e-04 | 190 | 74 | 4 | 26843ec1d19ac85a50990705353b802745d33e4d | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_cortex|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.81e-04 | 190 | 74 | 4 | 876bd2eb9ed2624cb23bdcf6b989e4fa34d099e3 | |
| ToppCell | NS-critical-d_0-4-Lymphoid|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.81e-04 | 190 | 74 | 4 | 84f9f5ac29ff0f929a589b76efa61d4c570e76b0 | |
| ToppCell | human_hepatoblastoma-Endothelial_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 2.81e-04 | 190 | 74 | 4 | 8d6ef93d69e96cd6921816d152bea3b0710cf147 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_cortex-lymphatic_endothelial_cell_of_renal_cortex|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.81e-04 | 190 | 74 | 4 | be9f36127028f52ca5fc1b32ba15a6c26aad69ac | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Endothelial-lymphatic_endothelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.81e-04 | 190 | 74 | 4 | 09a8855901c3c9332dbaab3e40166485b696d0f1 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Non-neuronal-Macroglial|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.81e-04 | 190 | 74 | 4 | ae97df1b06bcd46c05759b53c35dc8fea97f4ac1 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Non-neuronal|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.87e-04 | 191 | 74 | 4 | 2b056cbe2e82e056e1f798974999378460eb1d16 | |
| ToppCell | facs-Lung-24m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_aerocyte_endothelial_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.87e-04 | 191 | 74 | 4 | 40e617d3c93f03ae87baf6c0b2304b617f5fe782 | |
| ToppCell | facs-Pancreas-Endocrine-3m-Epithelial|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.87e-04 | 191 | 74 | 4 | 657297cd19d05a7e7bb74fc3a086fbd95f47aae4 | |
| ToppCell | COVID-19-kidney-AQP1+PLVAP+EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.93e-04 | 192 | 74 | 4 | 27ff3621e177e7932dd44dd6baa81551ea75a874 | |
| ToppCell | NS-moderate-d_07-13-Lymphoid-CTL|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.93e-04 | 192 | 74 | 4 | ab2c3d829f5cbf4eb386babcfdf851222a2a88e8 | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Endothelial-blood_vessel_EC-Fetal_arterial_EC|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.93e-04 | 192 | 74 | 4 | 5a0615fdc217554ccd611504b16e5d97628e207d | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Endothelial-blood_vessel_EC-Fetal_arterial_EC|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.93e-04 | 192 | 74 | 4 | 1f35efb0765e05f7f9c881849953bef3965be25a | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.93e-04 | 192 | 74 | 4 | 67d6230e32d446dcb12047fae2c3f1faa80dd720 | |
| ToppCell | facs-Aorta-Heart-3m|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.93e-04 | 192 | 74 | 4 | 1ccc47792edf9ee23501c8e2165d11271636b66a | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.93e-04 | 192 | 74 | 4 | bf1943715085c4124b1675888b0615c9500ec888 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.99e-04 | 193 | 74 | 4 | d1445b8bf2bab36e1a326ddb2a528151db016c7d | |
| ToppCell | moderate-Lymphoid-CTL|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 2.99e-04 | 193 | 74 | 4 | 3fce0807631811da1cff5ca9db23ff1ad36020e7 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.99e-04 | 193 | 74 | 4 | 010717ca052b6c8a525a43aaeffddea0d1113e63 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.99e-04 | 193 | 74 | 4 | 2189da4b727e25e62669d7b9257f06493be21a27 | |
| ToppCell | NS-moderate-d_16-33-Lymphoid-CTL|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 3.05e-04 | 194 | 74 | 4 | 6b2bb3dd11fd53fa9ab4d66c18b0714f96f99288 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L3-5_SST_MAFB|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.05e-04 | 194 | 74 | 4 | 83863da11dfbe59b2d0a2c08db40b537c150588c | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L3-5_SST_MAFB|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.05e-04 | 194 | 74 | 4 | 1bcb3fafd498614f7bac2b1c9b7de56e39110f65 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.05e-04 | 194 | 74 | 4 | 4f758718a1233c25c25d99fc1b7b06f906b8b0a2 | |
| ToppCell | 3'-Broncho-tracheal-Immune_Myeloid_mast-Myeloid_Mast/Baso-mast_cell-Mast_cells-Mast_cells_L.1.4.0.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.05e-04 | 194 | 74 | 4 | 9d7f232ef5f27c28f325edfa6614f479013acbba | |
| ToppCell | Posterior_cortex-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Pvalb-Inhibitory_Neuron.Gad1Gad2.Pvalb-Unc5b_(Neuron.Gad1Gad2.Pvalb-Unc5b)-|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 3.09e-04 | 79 | 74 | 3 | cc17a013a4a57a99c404b10449ef61ce559631d1 | |
| ToppCell | Posterior_cortex-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Pvalb-Inhibitory_Neuron.Gad1Gad2.Pvalb-Unc5b_(Neuron.Gad1Gad2.Pvalb-Unc5b)|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 3.09e-04 | 79 | 74 | 3 | 19fb2bc964589ea40e7b9f0809c641331c93dacd | |
| ToppCell | facs-Lung-nan-3m-Endothelial|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.11e-04 | 195 | 74 | 4 | 7f9b7f15006610ad591063d90e90367bd6083c7f | |
| ToppCell | MS-mDC2|MS / Condition, Cell_class and T cell subcluster | 3.17e-04 | 196 | 74 | 4 | 4707e4a911c6ea032f69aa1e431d5f4260bda011 | |
| ToppCell | MS-mDC2-|MS / Condition, Cell_class and T cell subcluster | 3.17e-04 | 196 | 74 | 4 | 064029b1376fa673f25f80596609be86ce0409a9 | |
| ToppCell | COVID-19-Myeloid-Transitioning_MDM|COVID-19 / group, cell type (main and fine annotations) | 3.17e-04 | 196 | 74 | 4 | 4929cfed1f150c1fde4d79cb49895c2ea467a18f | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW09-Macroglial-Glia_progenitor_cell|GW09 / Sample Type, Dataset, Time_group, and Cell type. | 3.17e-04 | 196 | 74 | 4 | 7be50b9156394dea44d7b8b476d4dd516abfafae | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb-3m|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.17e-04 | 196 | 74 | 4 | 151f1a29a91f8b234e9b6ed062666357a2f69128 | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Endothelial-blood_vessel_EC-Fetal_arterial_EC|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.23e-04 | 197 | 74 | 4 | 98e34e8612f111bb667a574de1faaa785d318ca4 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.23e-04 | 197 | 74 | 4 | 32b770e403028862f91e4727f4a8fbb6151910e4 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-3m-Macroglial-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.23e-04 | 197 | 74 | 4 | 7b12f9d4ad1e84df58e86591a491c84d4f36eac5 | |
| ToppCell | Severe_COVID-19-T/NK-CD8+_T|Severe_COVID-19 / Disease group,lineage and cell class （2021.01.30） | 3.29e-04 | 198 | 74 | 4 | 584f0dc6f22bb13956a5f6950698599e382907e9 | |
| ToppCell | BAL-Severe-Lymphocyte-T/NK-CD8+_T-CD8+_T-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 3.29e-04 | 198 | 74 | 4 | 2eb80255bacddbf778b1c9eec09f74b4cdb09b36 | |
| ToppCell | Control_saline-Endothelial-Endothelial-Activated_Gen_Cap|Control_saline / Treatment groups by lineage, cell group, cell type | 3.29e-04 | 198 | 74 | 4 | 3c3a5d2555f6af4aa33f9ea778808315d0e39d86 | |
| ToppCell | BAL-Severe-Lymphocyte-T/NK-CD8+_T|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 3.29e-04 | 198 | 74 | 4 | ec99da4e269c4cd982a395cdac0e4487ab14ec39 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-3m-Macroglial-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.29e-04 | 198 | 74 | 4 | fef9a4c96450078527b94d25e681410e4ea01b13 | |
| ToppCell | BAL-Severe-Lymphocyte-T/NK-CD8+_T-CD8+_T|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 3.29e-04 | 198 | 74 | 4 | 06fdf8554148d11c0a946a7fd200edd9fa7e1965 | |
| ToppCell | Bronchus_Control_(B.)-Stromal-TX-Smooth_muscle-2|Bronchus_Control_(B.) / Sample group, Lineage and Cell type | 3.35e-04 | 199 | 74 | 4 | 2c5ad62919c64ea0242e0984bb9932d2d975f4e3 | |
| Drug | Enoxacin [74011-58-8]; Down 200; 12.4uM; PC3; HT_HG-U133A | 2.63e-06 | 196 | 71 | 7 | 4655_DN | |
| Drug | Tiaprofenic acid [33005-95-7]; Up 200; 15.4uM; MCF7; HT_HG-U133A | 2.81e-06 | 198 | 71 | 7 | 4171_UP | |
| Drug | rotenone; Up 200; 1uM; PC3; HT_HG-U133A | 2.91e-06 | 199 | 71 | 7 | 5920_UP | |
| Drug | 8-N3cAMP | 1.03e-05 | 14 | 71 | 3 | CID006426627 | |
| Drug | 8-(6-aminohexyl)amino cyclic AMP | 1.03e-05 | 14 | 71 | 3 | CID000161999 | |
| Drug | GF109203X | 1.09e-05 | 341 | 71 | 8 | CID000002396 | |
| Drug | NA-382 | 1.29e-05 | 15 | 71 | 3 | CID000132534 | |
| Drug | phosphine oxide | 2.12e-05 | 107 | 71 | 5 | CID000166931 | |
| Drug | 8-azido cyclic AMP | 2.29e-05 | 18 | 71 | 3 | CID000115296 | |
| Drug | 8-thiomethyl-cAMP | 2.72e-05 | 19 | 71 | 3 | CID000093140 | |
| Drug | 8-azidoadenosine | 2.72e-05 | 19 | 71 | 3 | CID000160751 | |
| Drug | tyrphostin 23 | 3.13e-05 | 116 | 71 | 5 | CID000002052 | |
| Drug | Diphenidol hydrochloride [3254-89-5]; Down 200; 11.6uM; MCF7; HT_HG-U133A | 3.20e-05 | 194 | 71 | 6 | 7406_DN | |
| Drug | LY 294002; Down 200; 0.1uM; MCF7; HT_HG-U133A | 3.30e-05 | 195 | 71 | 6 | 5213_DN | |
| Drug | Apomorphine hydrochloride hemihydrate [41372-20-7]; Down 200; 6.4uM; HL60; HG-U133A | 3.39e-05 | 196 | 71 | 6 | 2005_DN | |
| Drug | CP-863187 [668981-07-5]; Down 200; 10uM; PC3; HT_HG-U133A | 3.49e-05 | 197 | 71 | 6 | 7512_DN | |
| Drug | Aconitine [302-27-2]; Down 200; 6.2uM; HL60; HG-U133A | 3.59e-05 | 198 | 71 | 6 | 1784_DN | |
| Drug | Etanidazole [22668-01-5]; Up 200; 18.6uM; MCF7; HT_HG-U133A | 3.69e-05 | 199 | 71 | 6 | 6072_UP | |
| Drug | tetraethylenepentamine pentahydrochloride; Up 200; 100uM; MCF7; HG-U133A | 3.69e-05 | 199 | 71 | 6 | 406_UP | |
| Drug | Sp-8-Cl-cAMPS | 4.29e-05 | 22 | 71 | 3 | CID000133987 | |
| Drug | 7B-forskolin | 7.18e-05 | 26 | 71 | 3 | CID000130638 | |
| Drug | H 85 | 7.18e-05 | 26 | 71 | 3 | CID006439306 | |
| Drug | lithium dimer | 7.18e-05 | 26 | 71 | 3 | CID000139759 | |
| Disease | Intellectual Disability | 6.76e-04 | 447 | 70 | 6 | C3714756 | |
| Disease | autosomal dominant intellectual developmental disorder (is_implicated_in) | 7.37e-04 | 17 | 70 | 2 | DOID:0060307 (is_implicated_in) | |
| Disease | alcohol use disorder (implicated_via_orthology) | 1.21e-03 | 195 | 70 | 4 | DOID:1574 (implicated_via_orthology) | |
| Disease | Intrahepatic Cholangiocarcinoma | 1.48e-03 | 24 | 70 | 2 | C0345905 | |
| Disease | Extrahepatic Cholangiocarcinoma | 1.48e-03 | 24 | 70 | 2 | C3805278 | |
| Disease | Cholangiocarcinoma | 1.74e-03 | 26 | 70 | 2 | C0206698 | |
| Disease | necrotizing enterocolitis | 1.87e-03 | 27 | 70 | 2 | EFO_0003928 | |
| Disease | type 2 diabetes mellitus (implicated_via_orthology) | 2.02e-03 | 105 | 70 | 3 | DOID:9352 (implicated_via_orthology) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| FPEPFVNTLPQARYY | 476 | O95936 | |
| ERFPYPFQVVYDEGP | 96 | Q06187 | |
| APFLYLQPSEVIYQP | 206 | Q8N9W6 | |
| LFDYFPKPYPNSEAA | 171 | P08574 | |
| PIYALQRNPFYPKNF | 366 | Q9GZS0 | |
| QIIPPAGYFQKVAEY | 221 | Q8TBG4 | |
| FYEPLQPPQVKALYL | 791 | Q6ZS30 | |
| LYVPVKEYPDFNFVG | 86 | Q96PU8 | |
| YPVLQIAEPFQYPQL | 1146 | Q9HCM3 | |
| YEPIFQDIFKYPQEE | 166 | Q08999 | |
| YPPFFADQPIQIYEK | 236 | P17612 | |
| ELAPDFYQPGPEYQK | 421 | Q9BR39 | |
| YKKIPNSNPPEYEFL | 561 | Q96JG8 | |
| FNSPYPKNYPPVVFK | 61 | P20916 | |
| FPKPLPQEYQYFDEL | 446 | Q96KR4 | |
| VNAYYLPTKNEIVFP | 606 | P0DPD6 | |
| AYLFFPPVVNPIVYS | 281 | Q9H342 | |
| QKEKPYFPIPEEYTF | 461 | Q00839 | |
| YFPIPEEYTFIQNVP | 466 | Q00839 | |
| KPPEYRNYQIVFIVF | 361 | Q6ZSS7 | |
| KPTIFYNLYVNPDEV | 41 | A8MZH6 | |
| VNPYPGIPVDANFYK | 886 | P36888 | |
| YSFNIPIEDKPQQFY | 866 | Q9P2N4 | |
| DLYGQPEPVKPFLFY | 106 | Q9NZH8 | |
| KANPVFDYQLYFQEP | 376 | P34913 | |
| YPPFFADQPIQIYEK | 236 | P22694 | |
| FPPFYADQPIQIYEK | 236 | P22612 | |
| LLQVFPKFPYDPSFN | 81 | A0A1B0GVN3 | |
| QPEYFYQPKGNEKVP | 201 | Q5U5Z8 | |
| EHPYFYPVVKEQSQP | 321 | P19784 | |
| PFRYPKEFQKLYPLE | 231 | P22304 | |
| KLFYYDEVTPPDYQP | 176 | Q86X24 | |
| PYPVFESNPEFLYVE | 596 | P78347 | |
| FLINSNYIEPKFPPF | 6 | Q00056 | |
| NYIEPKFPPFEEYAQ | 11 | Q00056 | |
| KYQVVYPFPTFQPAF | 221 | Q66K64 | |
| NKPVFIVPPYNYSYE | 701 | Q9BZA8 | |
| YPPAFQYETVVKPKV | 486 | Q9P2E2 | |
| DENKVPYFNAPVYLE | 91 | Q9NY12 | |
| PYFNAPVYLENKEQI | 96 | Q9NY12 | |
| PFKYSYPPLVDDDFQ | 236 | Q8NHP6 | |
| PFDDNYNTISYKPLP | 71 | Q9Y3Y4 | |
| QPSEYYLFQKPEVQP | 441 | Q8N2Y8 | |
| HYVELYEKPYPQPVQ | 446 | A6NKG5 | |
| VSKVDFSPQPPYNYA | 41 | Q8TED0 | |
| EFQEPVPASIPNYYK | 981 | Q9UPN9 | |
| SNPIYNEPDEPIAFY | 276 | Q9NP31 | |
| NAFPKEYIPTVFDNY | 26 | P84095 | |
| PYNHNPSEVKVPEFY | 856 | Q92540 | |
| ELPLPTFDVPYFKYI | 26 | Q92565 | |
| PPKNSFNNPAYYVLE | 976 | O15357 | |
| LVSPQYFAYPLQQEP | 211 | A0PJX4 | |
| YPFVQEPPVTEQKIY | 51 | Q96T21 | |
| FPPQYQEAVEPTVYV | 586 | Q9UHV7 | |
| QPYYYPPFDKIIEKA | 501 | P42338 | |
| PPFQTPKKLYAQEYE | 1086 | Q9ULL5 | |
| EFKEPVLPNNKYIYF | 336 | Q7L1T6 | |
| TPQAYDPLDVLVPYF | 211 | P51688 | |
| TPYPNEFQEPYAVVV | 366 | Q9Y2K9 | |
| DLYFLENYIKPPPVN | 131 | O43916 | |
| PIEKYQYPLFGLPFV | 1086 | Q9UHF7 | |
| LDPKPFPNYRANYNF | 116 | Q9NUL3 | |
| FIYNASKPQVPEYAP | 371 | Q9BS91 | |
| VPENYFYVPDLGQVP | 241 | A8MWX3 | |
| EENPYFPTYKFPELP | 411 | Q9BX66 | |
| LYLYQFQFFQEAVPP | 286 | Q9H5I5 | |
| VPENYFYVPDLGQVP | 226 | C4AMC7 | |
| FGPFYPQDYAATLPK | 1721 | Q9UGU0 | |
| PLPYFLQEPQDAYIV | 46 | Q8IZJ1 | |
| QQYFPKAPEFPSYKE | 676 | Q86UV5 | |
| PENYFYVPDLGQVPE | 211 | Q9NQA3 | |
| NPNYIYDVPPEFVIP | 2676 | O75962 | |
| FPEKQPFYVPFFAAY | 341 | Q8NBT3 | |
| QFQEPYLKDPAAYPK | 251 | Q9BZW5 | |
| INPFKFLPIYNPKYV | 186 | B2RTY4 | |
| INPFKFLPIYNPKYV | 186 | Q13459 | |
| KYQRVPYVEPPEYEF | 246 | Q99608 |